All In MedTech

Device Trial Radar · NCT05786196

Multicenter Glaucoma Study Investigating Standalone Canaloplasty

Multicenter Glaucoma Study Investigating Standalone Canaloplasty, Randomized Controlled Trial: iTrack Advance (Nova Eye, Inc.) Compared to OMNI (Sight Sciences)

Last checked: Nov 20, 2026Latest source record: Apr 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

86

Planned (sponsor's estimate)

Start

May 9, 2023

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Nova Eye, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Nova Eye Medical GmbH
First posted
Mar 27, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multicenter, randomized, clinical trial to evaluate the efficacy of canaloplasty performed as a standalone procedure using the iTrack™ Advance canaloplasty device (Nova Eye, Inc.) as compared to the OMNI® Surgical System (Sight Sciences) in patients with mild to moderate primary open-angle glaucoma.

Conditions

  • Primary Open Angle Glaucoma

Interventions

  • Ab-interno canaloplasty utilizing the iTrack Advance deviceDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

  • Ab-interno canaloplasty utilizing the OMNI Surgical SystemDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The mean change in unmedicated Intraocular pressure (IOP) at Month-12 compared to baselineTime frame: 12 months
  2. Percentage of eyes achieving a 20% or greater reduction in unmedicated Intraocular pressure (IOP) at Month-12 compared to baseline and without any other intervention (medication or secondary surgery)Time frame: 12 months

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • Breyer Kaymak Klabe Augenchirurgie

    Düsseldorf, Germany · Recruiting

  • Hospital Clinico San Carlos, Servicio de Oftalmologia

    Madrid, Spain · Recruiting

  • Princess Alexandra Eye Pavilion, NHS Lothian

    Edinburgh, United Kingdom · Recruiting

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.